Detalhe da pesquisa
1.
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers.
Gynecol Oncol
; 181: 68-75, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141533
2.
Moderate to severe distress in half of ovarian cancer patients undergoing treatment highlights a need for more proactive symptom and psychosocial management.
Gynecol Oncol
; 166(3): 503-507, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778291
3.
Navigating job and cancer demands during treatment: A qualitative study of ovarian cancer patients.
Gynecol Oncol
; 166(3): 481-486, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902296
4.
Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.
Gynecol Oncol
; 163(1): 85-92, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372972
5.
Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.
Gynecol Oncol
; 157(3): 765-774, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192732
6.
Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect.
Gynecol Oncol
; 157(3): 578-584, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32265057
7.
Corrigendum to 'Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer' [Gynecologic Oncology 157 (2020) 765-774].
Gynecol Oncol
; 159(1): 295, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839025
8.
Patient Portal Use Among Family Caregivers of Individuals With Dementia and Cancer: Regression Analysis From the National Study of Caregiving.
JMIR Aging
; 6: e44166, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235767
9.
Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance.
Mol Cancer Ther
; 20(9): 1542-1549, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172532
10.
The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer.
Expert Opin Investig Drugs
; 29(7): 639-644, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32408777
11.
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
Cancers (Basel)
; 12(3)2020 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213921
12.
Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer.
Ann Transl Med
; 8(13): 837, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793682